Rubio Assures NATO Allies on US Troop Deployment Plans Amid Policy Uncertainty Solar Panel Sales Surge as Businesses Seek LongTerm Energy Cost Savings Anthropic and Microsoft Discuss AI Chip Deal Following 5 Billion Investment Wingstop Shares Drop 12 After Earnings Miss Profit Expectations AI Talent Wars How Tech Giants and Startups Are Battling for the Future of Artificial Intelligence CPF LIFE vs SelfInvesting Retirement Decision Hinges on Financial Management in Old Age ArtsWay Manufacturing ARTW Q4 2024 Earnings Positive EPS Despite Market Headwinds Concord Medical Services CCM Q2 2016 Earnings EPS Falls Well Below Estimates as Stock Defies Negative Surprise ABT Q1 2026 Earnings EPS Falls Slightly Short of Estimates Shares Edge Lower MXC Q3 2025 Earnings Positive EPS of 022 Amid Quiet Quarter PubMatic Q1 2026 Earnings EPS Beats Estimates Shares Inch Higher ERII Q1 2026 Earnings EPS Miss Highlights Ongoing Cost Pressures Despite Stock Gain Franklin Financial Services FRAF Gains Ground Testing Key Levels After 225 Rally Lifevantage LFVN Surges Over 23 Key Levels to Watch After the Breakout DuPont DD Plunges 39 as Key Support Level Approaches What Investors Should Know Seanergy Maritime SHIP Slides 23 as Dry Bulk Sector Faces Headwinds Support at 1412 in Focus Trilogy Metals Inc TMQ Edges Higher as Price Nears Resistance Zone World Cup Campaigns May Be Reshaping Consumer Spending on Food Apparel and Travel Estee Lauder EL Q1 2026 Earnings Strong EPS Beat Drives DoubleDigit Stock Surge Materion Corporation MTRN Holds Steady Near Support Amid Marginal Decline Norfolk Southern NSC Slides Over 45 as Support Levels Come into Focus TMobile US Senior Notes TMUSI Edge Higher Yield Considerations and Key Levels Banco Bradesco BBD Edges Higher as Support Holds Key Levels to Watch NVIDIA Edges Higher as Support Holds Steady TH International THCH Edges Higher Consolidating Between Support and Resistance RXO Inc RXO Holds Steady Near Resistance as Trading Volume Signals Caution Black Diamond Therapeutics BDTX Shares Tumble Nearly 35 on Clinical Setback